Eikonoklastes Therapeutics

Developer of disruptive therapies designed to assist in the treatment of solid tumors and other pathologic conditions. The company's immunotherapies target the cell surface receptor by utilizing a rec...

Healthcare

Cincinnati, OH, United States

Founded 2019

8 employees

Website

Valuation

$100M

Market implied

Share Price

N/A

Total Raised

$25M

Last Round

N/A

Investors

+3 other investors

View all 3 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Eikonoklastes Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required